PTPA and hepatocellular carcinoma: PP2A dephosphorylates pAkt and CIP2A enhances PI3K/mTor signalling by inhibiting PP2A mediated dephosphorylation of pAKT in hepatocellular carcinomas (HCC) [20]; [21], [22].